rs199472676
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PS4_ModerateBP5
This summary comes from the ClinGen Evidence Repository: NM_000218.3(KCNQ1):c.217C>A (p.Pro73Thr) is a missense variant that causes substitution of proline with threonine at amino acid 73. This variant is present in gnomAD v.4.1.0 at a maximum allele frequency of 0.0002533, with 287 alleles / 1132988 total alleles in the European non-Finnish population, which is higher than the ClinGen Potassium Channel Arrhythmia VCEP PM2_Supporting threshold of <0.00001, but lower than the BS1 threshold of >0.0004, so neither criterion is met. This variant is rare and has been reported in at least 4 apparently unrelated probands affected with long QT syndrome 1 (PS4_Moderate; PMID:15840476, PMID:19716085, PMID:22949429, PMID:24606995, PMID:20851114). The variant has been reported to segregate with long QT syndrome 1 through a proband and 1 affected family member (PMID:26743238), which is not sufficient to meet PP1. This variant has been observed in 1 patient with an alternate molecular basis for disease (NM_000335.5(SCN5A):c.1231G>A (p.Val411Met)) with a phenotype that matches long QT syndrome 3 (BP5; PMID:28588847, PMID:23098067). This variant has also been observed in 1 patient with additional variants in KCNQ1 present both in cis (NM_000218.3(KCNQ1):c.502G>A (p.Gly168Arg)) and in trans (listed as p.Asp454Thrfs*7) providing an alternate molecular basis for disease (PMID:24667783), however, BP5 is only applicable when the phenotypes match another form of LQTS. The computational predictor REVEL gives a score of 0.566, which is below the ClinGen Potassium Channel Arrhythmia VCEP PP3 threshold of >0.75 but higher than the BP4 threshold of <0.25 and does not strongly predict a damaging effect on KCNQ1 function. The computational splicing predictor SpliceAI gives a score of 0.01 for donor gain, which is lower than the ClinGen Potassium Channel Arrhythmia VCEP PP3 threshold of >0.5 and does not strongly predict a damaging effect on KCNQ1 splicing. The Meiler Lab functional impact predictor (http://servers.meilerlab.org/servers/show?s_id=29) was unable to generate a prediction of functional impact for this variant due to a limitation of the model and the unavailability of secondary structure at this residue (PMID:29021305), so neither PS3_Supporting nor BS3_Supporting was met. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for long QT syndrome 1 based on the ACMG/AMP criteria applied, as specified by the ClinGen Potassium Channel Arrhythmia VCEP: PS4_Moderate, BP5. (VCEP specifications version 1.0.0; date of approval 03/04/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA006724/MONDO:0100316/112
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNQ1 | NM_000218.3 | c.217C>A | p.Pro73Thr | missense_variant | Exon 1 of 16 | ENST00000155840.12 | NP_000209.2 | |
| KCNQ1 | NM_001406836.1 | c.217C>A | p.Pro73Thr | missense_variant | Exon 1 of 15 | NP_001393765.1 | ||
| KCNQ1 | NM_001406838.1 | c.217C>A | p.Pro73Thr | missense_variant | Exon 1 of 11 | NP_001393767.1 | ||
| KCNQ1 | NM_001406837.1 | c.-146C>A | 5_prime_UTR_variant | Exon 1 of 17 | NP_001393766.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000859 AC: 13AN: 151300Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000153 AC: 23AN: 150334 AF XY: 0.000151 show subpopulations
GnomAD4 exome AF: 0.000215 AC: 291AN: 1353216Hom.: 0 Cov.: 31 AF XY: 0.000210 AC XY: 141AN XY: 671114 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000859 AC: 13AN: 151300Hom.: 0 Cov.: 32 AF XY: 0.0000541 AC XY: 4AN XY: 73910 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:5
- -
- -
Reported in association with LQTS (PMID: 15840476, 20851114, 23098067, 24606995, 26743238); Also reported in individuals who harbor an additional pathogenic variant that could explain their phenotype (PMID: 24667783, 29598884, 28588847); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24606995, 23098067, 19716085, 25351510, 22949429, 19862833, 19841300, 26633542, 20851114, 26986070, 28595573, 28588847, 28988457, 29197658, 29598884, 33181513, 31737537, 24667783, 15840476, 26743238, 22581653, 32048431, RidaM2023[Preprint], 37937776, 37449562) -
- -
- -
Long QT syndrome 1 Uncertain:2
- -
NM_000218.3(KCNQ1):c.217C>A (p.Pro73Thr) is a missense variant that causes substitution of proline with threonine at amino acid 73. This variant is present in gnomAD v.4.1.0 at a maximum allele frequency of 0.0002533, with 287 alleles / 1132988 total alleles in the European non-Finnish population, which is higher than the ClinGen Potassium Channel Arrhythmia VCEP PM2_Supporting threshold of <0.00001, but lower than the BS1 threshold of >0.0004, so neither criterion is met. This variant is rare and has been reported in at least 4 apparently unrelated probands affected with long QT syndrome 1 (PS4_Moderate; PMID: 15840476, PMID: 19716085, PMID: 22949429, PMID: 24606995, PMID: 20851114). The variant has been reported to segregate with long QT syndrome 1 through a proband and 1 affected family member (PMID: 26743238), which is not sufficient to meet PP1. This variant has been observed in 1 patient with an alternate molecular basis for disease (NM_000335.5(SCN5A):c.1231G>A (p.Val411Met)) with a phenotype that matches long QT syndrome 3 (BP5; PMID: 28588847, PMID: 23098067). This variant has also been observed in 1 patient with additional variants in KCNQ1 present both in cis (NM_000218.3(KCNQ1):c.502G>A (p.Gly168Arg)) and in trans (listed as p.Asp454Thrfs*7) providing an alternate molecular basis for disease (PMID: 24667783), however, BP5 is only applicable when the phenotypes match another form of LQTS. The computational predictor REVEL gives a score of 0.566, which is below the ClinGen Potassium Channel Arrhythmia VCEP PP3 threshold of >0.75 but higher than the BP4 threshold of <0.25 and does not strongly predict a damaging effect on KCNQ1 function. The computational splicing predictor SpliceAI gives a score of 0.01 for donor gain, which is lower than the ClinGen Potassium Channel Arrhythmia VCEP PP3 threshold of >0.5 and does not strongly predict a damaging effect on KCNQ1 splicing. The Meiler Lab functional impact predictor (http://servers.meilerlab.org/servers/show?s_id=29) was unable to generate a prediction of functional impact for this variant due to a limitation of the model and the unavailability of secondary structure at this residue (PMID: 29021305), so neither PS3_Supporting nor BS3_Supporting was met. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for long QT syndrome 1 based on the ACMG/AMP criteria applied, as specified by the ClinGen Potassium Channel Arrhythmia VCEP: PS4_Moderate, BP5. (VCEP specifications version 1.0.0; date of approval 03/04/2025). -
Cardiovascular phenotype Uncertain:1Benign:1
PS4_sup,PM1_sup,PP2,BP2,BP4 -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Beckwith-Wiedemann syndrome;C1837014:Atrial fibrillation, familial, 3;C1865019:Short QT syndrome type 2;C4551509:Jervell and Lange-Nielsen syndrome 1;C4551647:Long QT syndrome 1 Uncertain:1
- -
Short QT syndrome type 2 Uncertain:1
- -
Long QT syndrome Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 73 of the KCNQ1 protein (p.Pro73Thr). This variant is present in population databases (rs199472676, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of KCNQ1-related conditions (PMID: 15840476, 19716085, 22949429, 24606995, 24667783, 26743238, 28588847). ClinVar contains an entry for this variant (Variation ID: 53031). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt KCNQ1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Benign:1
Variant summary: KCNQ1 c.217C>A (p.Pro73Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00015 in 150334 control chromosomes, predominantly at a frequency of 0.00028 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in KCNQ1 causing Long QT Syndrome phenotype (8.3e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.217C>A has been reported in the literature in individuals affected with Long QT Syndrome (Example: Tester_2005, Kapa_2009, Kapplinger_2009, Marschall_2019, Millat_2011) etc . These data do not allow any conclusion about variant significance. Co-occurrences with other pathogenic variants have been reported (KCNH2 c.87C>A, p.Phe29Leu; SCN5A c.1231G>A, p.Val411Met; KCNQ1 c.502G>A, P.Gly168Arg) (Mullertz_2018, Magnusson_2017, Riuro_2015), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:19716085;PMID:19841300). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at